CNS pipeline · person
Joshua Reed
Chief Financial Officer of Alkermes, effective September 15, 2025. Previously CFO of Omega Therapeutics and Aldeyra Therapeutics, and held finance leadership roles at Bristol-Myers Squibb.
- 1 company
Courtesy Alkermes
Current roles
- Alkermes plcChief Financial Officer · Executive
Appears with
People sharing a company with Joshua.
- Blair Jackson · Alkermes plc
- Brian P. McKeon · Alkermes plc
- Cato T. Laurencin · Alkermes plc
- Christopher I. Wright · Alkermes plc
- Craig Hopkinson · Alkermes plc
- David Gaffin · Alkermes plc
- Frank Anders Wilson · Alkermes plc
- Nancy L. Snyderman · Alkermes plc
- Nancy S. Lurker · Alkermes plc
- Richard B. Gaynor · Alkermes plc
- Richard F. Pops · Alkermes plc
- Shane M. Cooke · Alkermes plc
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.